By Professor Sallie Pearson

Conference Abstracts

Daniels B; Pearson S-A; Vajdic CM; Pottegard A; Buckley NA; Buckley NA; Zoega H, 2020, 'Risks of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide (HCTZ)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno C; Costa JDO; Raichand S; Pearson S-A, 2020, 'The Australian pharmacoepidemiology research landscape: The more things change the more they stay the same', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 494 - 495, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640501433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costa JDO; Bruno C; Baranwal N; Pearson S-A, 2020, 'Variations in long-term opioid use definitions in observational research: A systematic review of studies using routinely collected data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 174 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Falster MO; Charrier R; Pearson S; Buckley N; Daniels B, 2020, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Virtual, Vol. 29, pp. 199 - 199, presented at 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, 16 September 2020

Vajdic CM; Perez-Concha O; Rhee J; Dobbins T; Ward R; Schaffer A; Van Leeuwen MT; Laaksonen M; Craigen G; Pearson S, 2019, 'Risk factors for cancer registry-notified cancer of unknown primary site (CUP)', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, Vol. 15, pp. 84 - 85, presented at Clinical Oncology Society of Australia 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13262

Chiu T; Pearson S; Schaffer A, 2019, 'Pregabalin use outside subsidy restrictions in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, Vol. 28, pp. 252 - 253, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Daniels B; Wylie C; Pearson S-A; Brett J; Buckley N, 2019, 'A day in the life: Prescription medicine use in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 545 - 545, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno C; Pearson S-A; Daniels B; Buckley N; Zoega H, 2019, 'Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 519 - 519, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Buckley NA; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson S-A; Dunlop AJ; Degenhardt L, 2019, 'CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S82

Falster M; Schaffer A; Jorm L; Wilson A; Brieger D; Nasis A; Emerson L; Pearson S, 2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, Vol. 3, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640

Gisev N; Pearson S; Larance B; Larney S; Blanch B; Degenhardt L, 2018, 'The safety of fentanyl patch initiation in Australian clinical practice: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 437 - 437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893804049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Homaira N; Daniels B; Pearson S; Jaffe A, 2018, 'PATTERNS OF PRESCRIBED ASTHMA MEDICINE USE IN AUSTRALIAN CHILDREN: A POPULATION-BASED STUDY', in RESPIROLOGY, WILEY, Vol. 23, pp. 107 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427591800192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, Vol. 27, pp. s333, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia, http://dx.doi.org/10.1016/j.hlc.2018.06.647

Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Vol. 27, pp. s356, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, http://dx.doi.org/10.1016/j.hlc.2018.06.701

Schaffer AL; Buckley NA; Pearson S, 2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Pearse J; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf

James P; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf

Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)

Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5)

Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S; Dunbar J; McDermott R; Smyth T; Henryks J; Bower M; Rosen R; Sutch S; McDonald K; Lethborg A; Dove C, 2021, Evaluation of the Health Care Homes program - Interim evaluation report 2020 Volume 1: Summary report, https://www1.health.gov.au/internet/main/publishing.nsf/Content/Evaluation-of-the-Health-Care-Homes-Program

Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes PHN Benchmark Report: January 2020 - June 2020 (Round 4)

Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes Practice Benchmark Report: January 2020 - June 2020 (Round 4)

Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S; Dunbar J; McDermott R; Smyth T; Henryks J; Bower M; Rosen R; Sutch S; McDonald K; Lethborg A; Dove C, 2020, Evaluation of the Health Care Homes program - Interim evaluation report 2019, Volume 1: Summary report

Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes PHN Benchmark Report: June 2019 - December 2019 (Round 3)

Tran D; Falster M; Pearson S; Jorm L, 2020, Health Care Homes Practice Benchmark Report: June 2019 - December 2019 (Round 3)

Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S, 2019, Evaluation of the Health Care Homes program - Evaluation plan

Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Practice Benchmark Report: February 2018 - June 2019 (Round 2)

Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - June 2019 (Round 2)

Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Practice Benchmark Report: February 2018 - December 2018 (Round 1)

Tran D; Falster M; Pearson S; Jorm L, 2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - December 2018 (Round 1)

Schaffer A; Falster M; Pearson S; Jorm L; Wilson A; Nasis A; Brieger D, 2018, Delivering better cardiac outcomes: Primary, specialist and hospital care

Zoega H; Schaffer A; Litchfield M; Pearson S, 2017, Post-market Review - Pulmonary Arterial Hypertension Medicines

Preprints

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk M-H; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson S-A; Reutfors J; Furu K; Cohen JM; Zoega H, 2023, Antipsychotic Use During Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort Study, http://dx.doi.org/10.2139/ssrn.4652505

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson S-A; Donovan P; Coory M; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764

Liu B; Stepien S; Dobbins T; Gidding H; Henry D; Korda R; Mills L; Pearson S-A; Pratt N; Vajdic C; Welsh J; Macartney K, 2023, Effectiveness of COVID-19 Vaccination Against Covid-19 Specific and All-Cause Mortality in Older Australians, http://dx.doi.org/10.2139/ssrn.4445191

Hong S; Daniels B; Leeuwen MT; Pearson S-A; Vajdic CM, 2021, Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors, http://dx.doi.org/10.21203/rs.3.rs-1006781/v1

Yin X; Liu H; Webster J; Trieu K; Huffman MD; Miranda JJ; Marklund M; Wu JHY; Cobb LK; Li KC; Pearson S-A; Neal B; Tian M, 2021, Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint), http://dx.doi.org/10.2196/preprints.27423

de Oliveira Costa J; Gillies M; Schaffer A; Peiris D; Zoega H; Pearson S-A, 2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), http://dx.doi.org/10.1101/2021.11.24.21266837

Schaffer A; Henry D; Zoega H; Elliott J; Pearson S-A, 2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, http://dx.doi.org/10.1101/2021.09.26.21264150

Costa JDO; Bruno C; Baranwal N; Gisev N; Dobbins T; Degenhardt L; Pearson SA, 2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019), http://dx.doi.org/10.22541/au.160192979.95446629/v1

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson S-A, 2018, Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: a national population-based observational study (2001-2016), http://dx.doi.org/10.1101/324343

Other

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.c.7061343

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.c.7061343.v1

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151343

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151343.v1

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151340

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson S-A; Chiew K-L; Bulsara MK; Houssami N, 2024, Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151340.v1

Back to profile page